Your revenue cycle team delivers another batch of denials for procedures performed in your hospital’s outpatient department for years. The reason? The payer claims the service should have been performed in a lower-cost setting.
Site of care denials represent one of the fastest-growing denial categories hospitals face in 2026. As the Centers for Medicare and Medicaid Services (CMS) accelerates site-neutral payment policies and commercial payers challenge where procedures are performed, hospitals face regulatory flexibility paired with reimbursement restrictions that create significant revenue risk.
Understanding Site of Care Denials
Site of care denials occur when payers reject claims based on where a service was performed rather than medical necessity. Unlike traditional denials, questioning whether a procedure was appropriate, site of care denials accept the clinical necessity but challenge the location choice. The denial might state that a procedure billed in a hospital outpatient department should have been performed in a physician’s office, ambulatory surgery center, or a different facility type.
The financial impact is enormous. Medicare pays substantially less for services performed in physician offices compared to hospital-owned facilities. When payers deny these claims and demand the lower rate, hospitals absorb substantial losses per procedure.
What makes site of care denials particularly challenging is that they often target procedures clinically appropriate for the hospital setting based on patient acuity, comorbidities, or safety concerns. The payer isn’t questioning whether the patient needed the procedure, but whether they needed it performed in your facility with hospital-level resources and monitoring.
CMS Site Neutral Payment Expansion
CMS finalized aggressive site-neutral payment policies in its 2026 Hospital Outpatient Prospective Payment System rule. The agency now pays drug administration services furnished in grandfathered off-campus hospital outpatient departments at significantly reduced rates compared to the standard hospital rate, effectively applying Physician Fee Schedule rates to these services. Rural sole community hospitals received exemptions, but most facilities face these reduced payments starting January 2026.
CMS projects this single policy change will reduce hospital spending substantially in 2026 alone, with site-neutral expansion potentially saving billions over the next decade by reducing payments for services the agency believes can be safely performed in lower cost settings. The Congressional Budget Office estimates current payment differentials could cost taxpayers substantial amounts if unaddressed.
The policy stems from CMS’s authority to control unnecessary increases in service volume. The agency argues that when Medicare pays significantly more for services in hospital settings, it creates financial incentives to shift care to higher cost locations even when clinically unnecessary.
For hospitals, this creates immediate operational challenges. Services previously reimbursed at full hospital rates now generate significantly less revenue. Facilities must quickly determine which services can shift to lower cost settings, which patients truly require hospital-level care, and how to document medical necessity when hospital care remains clinically appropriate despite lower reimbursement.
The Inpatient Only List Elimination
CMS is eliminating the Inpatient Only (IPO) List by January 1, 2028, beginning in 2026, by removing hundreds of procedures, primarily musculoskeletal surgeries. These procedures can now be performed and reimbursed in outpatient settings, including hospital outpatient departments and ambulatory surgery centers. The policy adds substantial numbers of procedures to the Ambulatory Surgical Center Covered Procedure List, with plans for hundreds more as the list phases out.
CMS temporarily exempts these procedures from certain medical review activities under the two-midnight rule, including site of service claim denials and Recovery Audit Contractor referrals. However, this exemption ends once CMS determines a procedure is more commonly performed in the outpatient setting than inpatient.
The elimination doesn’t mandate outpatient surgery; it simply removes the requirement that certain complex procedures must be performed inpatient for Medicare to reimburse them. Physicians retain discretion to admit patients based on clinical judgment, but this flexibility comes with significant risk.
Total knee arthroplasty (TKA) provides a cautionary example. When CMS removed TKA from the IPO list in January 2018, very few TKA patients were outpatient. Within two years, the majority of Medicare TKA patients were classified as outpatient. Most concerning, a significant percentage of outpatient-designated patients remained hospitalized for more than a day, yet they were still classified and billed as outpatients to avoid denials.
These outpatient classified patients experienced higher readmission rates and more emergency visits than true inpatients. Commercial payers quickly followed Medicare’s lead, denying all inpatient TKA claims and demanding outpatient billing regardless of patient complexity or comorbidities. This pattern will likely repeat as CMS removes additional procedures from the IPO list in 2026 and beyond.
Commercial Payer Denial Tactics
Medicare Advantage and commercial insurers weaponize the site of care criteria to reduce reimbursement. Denial rates for Medicare Advantage plans remain substantially higher compared to commercial plans and traditional Medicare. Site of care issues contribute significantly to these elevated denial rates.
Payers deny claims by asserting services should have been performed in lower cost settings, often after the fact. Pre-authorization provides no protection. The authorization might approve the procedure but specify a different site of care than where it was actually performed. Or the payer might argue that patient selection was inappropriate, claiming the patient’s comorbidities didn’t justify hospital-level care despite clinical documentation supporting that decision.
The average denied amount for Medicare Advantage claims has risen substantially. Denials related to medical necessity and site of care have increased dramatically. While a significant percentage of Medicare Advantage denials are ultimately reversed, hospitals only recover revenue after multiple costly appeal rounds that can take months to resolve.
Payer audits have surged dramatically in recent years, with site of care compliance emerging as a primary focus. Recovery Audit Contractors specifically target procedures removed from the IPO list, challenging whether inpatient admission was justified or whether the procedure should have been performed in an ambulatory surgery center.
Place of Service Code Complexity
Accurate Place of Service (POS) coding forms the foundation of site of care compliance, yet a substantial percentage of claim denials continue to result from incorrect POS code usage. These two-digit codes specify where services were rendered (physician office, hospital outpatient, emergency room, ambulatory surgery center) and carry different reimbursement implications.
Healthcare organizations report that significant percentages of outpatient claims are denied due to incorrect POS code usage. Research shows substantial numbers of outpatient hospital claims face delays due to mismatched POS codes.
Common errors include billing emergency services under the wrong POS code for urgent care instead of the emergency room or submitting hospital outpatient services with office visit codes instead of proper outpatient hospital codes. Medicare reimburses non-facility settings at higher rates than facility settings because hospitals absorb overhead costs. Using the wrong code either leaves money on the table or triggers denials.
Pre Authorization and Documentation Requirements
Pre-authorization processes now specify exactly where procedures can be performed, not just whether they’re medically necessary. Payers require site-specific authorization, creating a new denial vector when the care setting changes based on clinical findings.
A patient arrives for a pre-authorized outpatient procedure, but upon evaluation, the physician identifies comorbidities requiring overnight observation. The clinical decision to admit is appropriate, but the payer denies payment because the authorization specified outpatient care. Some payers even deny authorizations retroactively, asserting procedures should have been performed outpatient months after approving inpatient admission.
Documentation must justify why the specific care setting was chosen. For procedures performed in multiple settings, medical records should address patient-specific factors like advanced age, complex comorbidities, anticoagulation status, or obesity that increase procedural risk and necessitate hospital-level care. The two midnight rule remains in effect even as the IPO list disappears, requiring documented clinical reasoning for inpatient admissions. Organizations focused on clinical documentation improvement implement systematic approaches to ensure proper justification for site of care decisions.
Proactive Site of Care Risk Assessment
Hospitals must shift from reactive denial management to proactive site of care compliance. This begins with systematic risk assessment protocols that evaluate whether the planned care setting aligns with payer expectations before procedures are scheduled.
Develop site-specific patient selection criteria that balance clinical appropriateness with reimbursement realities. Which comorbidity thresholds require inpatient admission despite a procedure’s removal from the IPO list? Risk assessment tools should integrate into scheduling workflows, flagging cases likely to generate site-of-care denials before authorization requests.
Continuous monitoring identifies denial patterns before they escalate. Are payers consistently denying specific procedure types? Do particular surgeons’ cases generate elevated denials because patient selection differs from payer expectations? Real-time analytics surface these patterns when intervention can still change outcomes.
MDaudit’s compliance audits platform enables hospitals to monitor site of care compliance across their enterprise. Rather than discovering denials months after submission, continuous monitoring identifies gaps while cases are in process. Providers receive alerts when documentation is insufficient, when POS codes don’t match service locations, or when patient selection falls outside site-specific criteria.
Behavioral Artificial Intelligence (AI) trained on past audit findings learns which site of care scenarios generate denials from specific payers. The system recognizes patterns human auditors might miss, such as subtle differences in how payers apply site-neutral policies or which documentation elements they require to approve hospital-level care.
Strategic Response to Site Neutral Expansion
Hospitals need comprehensive strategies coordinating clinical operations, revenue cycle management, and compliance functions around site of care optimization.
Determine which services to shift to lower cost settings. Can some outpatient procedures migrate to ambulatory surgery centers without compromising quality? This analysis must account for patient selection, facility capabilities, payer mix, and physician preferences. For services remaining in hospital settings despite payment reductions, aggressively defend the medical necessity of that setting choice through standardized documentation protocols.
Staff education becomes critical as policies evolve. Surgeons need to understand which procedures payers expect in ambulatory versus hospital environments. Registration staff must accurately capture facility information for correct POS coding. Coders need training on nuanced differences between facility types. Provider education programs help ensure all team members understand the site of care requirements.
Revenue cycle teams need robust appeals processes specifically designed for site-of-care denials. These require clinical arguments, not just coding corrections. Appeals should include physician statements explaining why patient-specific circumstances required the care setting used, supported by clinical guidelines demonstrating best practices for similar patients.
Conclusion
Site of care denials represent a fundamental shift in how payers control healthcare spending. Rather than questioning whether patients need procedures, payers now challenge where those procedures should be performed, leveraging site-neutral payment policies and IPO list elimination to drive care toward lower cost settings.
Hospitals must balance clinical appropriateness with reimbursement realities. Physicians must retain the ability to choose care settings based on patient-specific factors, but those choices increasingly require documentation justifying hospital-level care against payer expectations of ambulatory alternatives. POS code accuracy becomes mission-critical as even minor errors trigger automatic denials.
Proactive compliance strategies offer the only sustainable path forward. Continuous monitoring identifies sites of care risks before claims are submitted, when documentation can still be improved, and care settings adjusted. Risk assessment protocols ensure patient selection aligns with both clinical best practices and payer criteria. Behavioral AI learns which site of care scenarios generate denials and what documentation payers accept.
The question isn’t whether hospitals will face increasing sites of care denials; that’s inevitable. The question is whether hospitals will discover these denials months after submission through reactive denial management or identify and address risks proactively before revenue is lost. In a landscape where payer audits and site of care denial amounts have risen dramatically, waiting for denials to arrive is no longer viable.
If you’re ready to shift from reactive to proactive site of care compliance, contact MDaudit to learn how our compliance platform can help protect your revenue.
